News|Articles|December 2, 2004
- Pharmaceutical Technology-12-02-2004
- Volume 28
- Issue 11
Acceptable Analytical Practices for Dissolution Testing of Poorly Soluble Compounds
This article provides guidance for developing dissolution testing for poorly soluble compounds. It is the second of a series of articles based on material from a 2003 PhRMA workshop about acceptable analytical practices.
Advertisement
Articles in this issue
over 21 years ago
In the Spotlight-December 2004over 21 years ago
Safety Problems Roil Pharma and FDAover 21 years ago
December 2004over 21 years ago
Robust CRO Market Is Driving New Merger and Acquisition Activityover 21 years ago
The Seventh Annual International Employment Surveyover 21 years ago
Pharmaco-FakeryAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations
2
Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.
3
Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?
4
Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands
5